# P020023: Restylane Injectable Gel

- Pathway: PMA
- Applicant: Q-Med AB
- Decided: Dec 12, 2003 after 541 days
- Product code: LMH (Implant, Dermal, For Aesthetic Use)
- Device class: 3
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. PMA decisions do not claim a predicate device.

Source page: https://510kreport.com/device/P020023
Methodology: https://510kreport.com/methodology